A 24-week double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group - Rogers,S.L.; Farlow,M.R.; Doody,R.S.; Mohs,R.; Friedhoff,L.T. (Neurology, 1998)